Fuller & Thaler Asset Management
TARA icon

Fuller & Thaler Asset Management’s Protara Therapeutics TARA Stock Holding History

Fuller & Thaler Asset Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-43
Closed -$26K – 872
2015
Q4 		$26K Buy
+43
New +$25.2K ﹤0.01% 691

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Fuller & Thaler Asset Management's TARA Position: Q1 2016 in Review

Fuller & Thaler Asset Management sold out of Protara Therapeutics (TARA) in Q1 2016, closing a stake of 43 shares — an estimated $26K sold.

Fuller & Thaler Asset Management first reported a position in TARA in Q4 2015 and held it in 1 quarter. The position peaked at $26K in Q4 2015. 43 funds tracked by Wall St. Rank hold TARA as of Q1 2016.

  • Fuller & Thaler Asset Management reported no remaining Protara Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 43 Protara Therapeutics shares in Q1 2016, an estimated $26K.
  • Fuller & Thaler Asset Management first reported a position in Protara Therapeutics in Q4 2015 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's Protara Therapeutics position peaked at $26K in Q4 2015.
  • 43 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2016.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2016, filed 12 May 2016.